Effects of a Self-Regulation Based E-MOTE Program Delivered Via an AI-Assisted Robot and Supported by Mobile Platforms for Newly Diagnosed Gynecologic Cancer Patients
Effects of a Self-Regulation-Based E-MOTE Emotional Care Program Delivered Via an AI-Assisted Robot and Supported by Mobile Platforms for Newly Diagnosed Gynecologic Cancer Patients From Surgery to 6-Month Post-Discharge
1 other identifier
interventional
120
1 country
1
Brief Summary
To evaluate the effectiveness of the E-MOTE Emotional Care Program, delivered through the Kebbi robot and the LINE Official Account, for patients newly diagnosed with gynecologic cancer undergoing surgery. The primary outcomes are psychological distress , and the secondary outcomes are physical symptoms, stress index, and quality of life.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Sep 2026
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 30, 2026
CompletedFirst Posted
Study publicly available on registry
August 4, 2026
CompletedStudy Start
First participant enrolled
September 1, 2026
ExpectedPrimary Completion
Last participant's last visit for primary outcome
July 31, 2028
Study Completion
Last participant's last visit for all outcomes
July 31, 2028
August 4, 2026
July 1, 2026
1.9 years
July 30, 2026
July 30, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Distress
Investigators utilized the Distress Thermometer(DT) as the primary outcome measure. The scale uses a 11 Liker scale, where 0 indicates no distress at all and 10 represents the most severe distress.Higher score indicates a more severe distress. When the score is 4 or higher, a Problem List (PL) is used to further identify factors contributing to the emotional distress.
Measurements will be taken before the intervention, three days after surgery, and one week after discharge.
Depression
Investigators utilized the Patient Health Questionnaire (PHQ-9) as the primary outcome measure to assess depression. The scale consists of 9 items, each rated on a 4-point Likert scale (0 = not at all, 3 = nearly every day). The total score ranges from 0 to 27, and depression severity can be categorized as mild (5-9), moderate (10-14), moderately severe (15-19), and severe (20 or above).Higher score indicates a more severe depression.
Measurements will be taken before the intervention, three days after surgery, and one week after discharge
Secondary Outcomes (3)
Quality of Life Measurement
Measurements will be taken before the intervention, three days after surgery, and one week after discharge
Symptom Severity
Measurements will be taken before the intervention, three days after surgery, and one week after discharge
Stress Index
Measurements will be taken before the intervention, three days after surgery, and one week after discharge
Study Arms (2)
Control Group
NO INTERVENTIONRoutine care
Intervention Group
EXPERIMENTALThe intervention group will receive the E-MOTE program, which includes emotional assessments, a self-relaxation training session, and a Q\&A session delivered via the Kebbi AI robot during hospitalization. After discharge, participants will continue to receive the program through the LINE Official Account.
Interventions
Participants in the experimental group will receive the E-MOTE program during hospitalization on the day before surgery, postoperative day 1, and postoperative day 2 via the AI robot. The intervention includes an emotional assessment, followed by dialogue modules tailored to the participant's level of emotional distress, emotion-generated empathetic conversations, a self-affirmation relaxation training session, and a Q\&A session. After discharge, participants will continue to receive the E-MOTE program through the LINE Official Account.
Eligibility Criteria
You may qualify if:
- Aged 18 years or older.
- Diagnosed with gynecologic cancer and undergoing surgery.
- Willing to receive E-MOTE robot and wear a smart wearable device.
- Willing to complete pre-test and post-test questionnaires.
You may not qualify if:
- Unable to communicate clearly.
- Unwilling or unable to participate in the study in its entirety.
- \*\*\*Nurse\*\*\*
- Aged 18 years or older.
- As a clinical nurse and has cared for patients who received the E-MOTE robot
- \- Unwilling to participate in the qualitative interview.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
National Taiwan University
Taipei, Taiwan
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 30, 2026
First Posted
August 4, 2026
Study Start (Estimated)
September 1, 2026
Primary Completion (Estimated)
July 31, 2028
Study Completion (Estimated)
July 31, 2028
Last Updated
August 4, 2026
Record last verified: 2026-07